NASDAQ · VMD
Healthcare · Medical - Devices
$9.24
Up+$0.09 (+0.97%)
Updated Oct 6, 2026, 10:07 PM
SID Score
6.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · VMD
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
VMD closed at $9.24 after 20 trading sessions, up 5.12% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $9.15 | $9.30 | $9.09 | $9.24 | 217.81K |
| Oct 2, 2026 | $9.17 | $9.17 | $8.91 | $9.13 | 387.73K |
| Oct 1, 2026 | $9.08 | $9.20 | $9.03 | $9.08 | 265.01K |
| Sep 30, 2026 | $9.19 | $9.2374 | $8.95 | $9.10 | 253.98K |
| Sep 29, 2026 | $9.01 | $9.24 | $8.96 | $9.23 | 230.9K |
| Sep 28, 2026 | $8.92 | $9.12 | $8.83 | $9.11 | 336.52K |
| Sep 25, 2026 | $8.81 | $8.9257 | $8.71 | $8.91 | 199.82K |
| Sep 24, 2026 | $8.80 | $8.855 | $8.66 | $8.82 | 255.61K |
| Sep 23, 2026 | $8.95 | $8.97 | $8.78 | $8.80 | 213.42K |
| Sep 22, 2026 | $8.85 | $9.01 | $8.83 | $8.96 | 241.59K |
| Sep 21, 2026 | $8.90 | $8.97 | $8.69 | $8.85 | 265.05K |
| Sep 18, 2026 | $8.97 | $9.06 | $8.86 | $8.91 | 414.56K |
| Sep 17, 2026 | $8.94 | $9.0175 | $8.88 | $8.95 | 317.4K |
| Sep 16, 2026 | $8.78 | $8.96 | $8.75 | $8.94 | 344.96K |
| Sep 15, 2026 | $8.82 | $8.82 | $8.70 | $8.75 | 178.39K |
| Sep 14, 2026 | $8.83 | $8.98 | $8.76 | $8.84 | 226.38K |
| Sep 11, 2026 | $8.81 | $8.92 | $8.7006 | $8.79 | 202.21K |
| Sep 10, 2026 | $8.74 | $8.819 | $8.695 | $8.75 | 236.63K |
| Sep 9, 2026 | $8.73 | $8.84 | $8.595 | $8.76 | 399.4K |
| Sep 8, 2026 | $8.85 | $8.99 | $8.74 | $8.79 | 335.58K |
The latest Smart Investors Daily articles mentioning VMD.
Company
Market Activity
Research & News
VMD research
Company profile and research snapshot.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 24, 2026 | Barrington Research | Outperform | — |
| Aug 6, 2026 | Freedom Broker | Hold | — |
| Nov 3, 2021 | RBC Capital | Outperform | — |
| Mar 5, 2021 | RBC Capital | Outperform | — |
No generated briefing is available yet.
SeekingAlpha · Sep 28, 2026
Viemed Healthcare (VMD) is evolving from a capital-intensive respiratory equipment company into a diversified, capital-light home healthcare provider.
Yahoo · Sep 24, 2026
LAFAYETTE, LA / ACCESS Newswire / September 24, 2026 / (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that Michael Moore, President of Viemed, has adopted an automatic securities disposition plan (the "ASDP") relating to common shares of the Company.Under applicable securities laws, insiders are subject to limits on their ability to sell shares.
Yahoo · Sep 4, 2026
Viemed Healthcare’s updated analyst model now places fair value at $12.50, compared with the previous $11.00 estimate, which signals a reset in how the stock is being framed. Supportive analysts link this change to Viemed Healthcare’s position in home respiratory care and its exposure to a broader mix of equipment, while more cautious voices point to near term profitability pressures and a tighter margin of safety. As you read on, you will see how these shifting views shape the evolving...
Yahoo · Aug 29, 2026
Viemed Healthcare (NASDAQ:VMD) outlined its growth strategy, product diversification and capital allocation priorities at the Midwest IDEAS Conference, emphasizing its focus on providing in-home care for patients with complex respiratory conditions. Chief Executive Officer Casey Hoyt said complex r
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning VMD.
